HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

4th Edition of

International Ophthalmology Conference

March 23-25, 2026 | Singapore

IOC 2026

5 year comparison of safety and efficacy of iStent G1 and KDB goniotomy in primary open angle glaucoma

Speaker at International Ophthalmology Conference 2026 - Ejaz Ansari
Canterbury Christ Church University, United Kingdom
Title : 5 year comparison of safety and efficacy of iStent G1 and KDB goniotomy in primary open angle glaucoma

Abstract:

Background: Minimally invasive glaucoma surgery (MIGS) has been adopted worldwide for the surgical treatment of primary open angle glaucoma (POAG). However, more studies are needed comparing the long-term efficacy of different procedures.

Aims and objectives: Long-term comparison of efficacy and safety of iStent (G1) and KDB goniotomy, combined with phacoemulsification + IOL, through to 5 years.

Methods: A retrospective, real world, non-randomised, comparative study. Single centre. Primary outcome measure was number of cases achieving 20% or more IOP reduction from baseline; secondary outcome measures were change in drop dependence visual field mean deviation (VFMD) through to 5 years and adverse events.

Results: There were no significant differences in IOP reduction, number of cases achieving 20% reduction in IOP or VFMD at each time point through to 5 years. At each time point, the KDB group achieved significantly less drop dependence (p<0.001). There was a low rate of adverse events, and no cases of serious adverse events.

Conclusions: There was long-term success with each device with few transient adverse effects. The only difference between groups was the reduction in drop dependence that was immediate and persistent for the entire follow-up period in favour of KDB goniotomy.

Watsapp